Bausch + Lomb
Focus: Bausch + Lomb is a specialized ophthalmology-focused pharmaceutical company headquartered in New Jersey, with a public listing and deep expertise in eye care therapeutics and devices. The company maintains a diversified portfolio spanning dry eye disease, glaucoma, and surgical care products.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
Recent layoff filing — 49 affected
- 8/13/2025 — 1330 Redwood Way Petaluma CA 94954, CA · 49 affected · Closure
Source: state DOL filings via Big Local News
About Bausch + Lomb
AI assessmentNot HiringNo open roles listed right now. Follow Bausch + Lomb to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
4/9 — Basic
Company HealthWatch
Pipeline
Early-stage
50 total
LOE Risk
3 imminent
APLENZIN
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$473M Part DStable
Peak7.6yr
Flagship product generating half of company revenue with extended patent protection through 2033, representing core value and immediate job security.
Help build intelligence for Bausch + Lomb
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.